Please note, this OEL/ADE monograph also applies to Thymopentin monoacetate (CAS RN 177966-81-3; 89318-88-7). Thymopentin is a synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties (1). It is indicated for the treatment of autoimmune diseases (such as acquired immunodeficiency syndrome (AIDS), rheumatoid arthritis, and systemic lupus erythematosus), a variety of primary or secondary Tcell deficiency diseases (such as children with congenital immunodeficiency disease), patients with chronic hepatitis B over 18 years of age, types of the low cellular immune function diseases, atopic dermatitis, and adjuvant therapy for tumors.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Thymopentin, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.